Reduced fruquintinib dose showed no significant survival association in colorectal cancer cohort
In a multicenter retrospective cohort of 69 patients with refractory metastatic colorectal cancer, an initial fruquintinib dose below 5 mg ...
Tag: dose optimization
Low-Dose Nivolumab Shows Responses in Retrospective Nepal Cancer Cohort
A retrospective Nepalese cohort of 31 patients associated 20- or 40-milligram nivolumab with responses across advanced cancers, but uncontrolled evidence ...
Lower Lenvatinib Starting Doses Show No Clear Advantage in Advanced Endometrial Cancer
A new systematic review and meta-analysis finds that starting lenvatinib below 20 mg with pembrolizumab neither clearly preserves tumor response ...
A gentler chemo schedule may match standard care in advanced pancreatic cancer
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
AI Framework Aims to Personalize Radiation Doses for GI Brain Metastases
Researchers at the University of Pittsburgh have developed THINKERS-GI, a mixture-of-experts artificial intelligence framework that predicts local failure and toxicity ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!